Craig-Hallum Sticks to Their Buy Rating for Guardant Health (GH)
Craig-Hallum analyst William Bonello maintained a Buy rating on Guardant Health (GH – Research Report) today. The company’s shares closed ...
Guardant Health Announces Debt Exchange Transactions
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on February 6, 2025, it ...
Are Medical Stocks Lagging Guardant Health (GH) This Year?
Here is how Guardant Health (GH) and Alnylam Pharmaceuticals (ALNY) have performed compared to their sector so far this year.
FOX 4 Dallas-Fort Worth on MSN5d
New blood test helps Texas doctors detect colon cancer in patients earlier
Doctors in Dallas and other parts of Texas are beginning to use a new blood test that can detect colon cancer earlier. The ...
Axios Austin on MSN5d
Austin gets access to new blood tests for colorectal cancer
Austin patients are among the first in the country to have access to a new blood test capable of screening for colorectal ...
360dx6d
360Dx Top 30 Rockets 10 Percent in January
Of the 30 companies included, 19 companies saw their stock price increase, eight firms saw their share price decrease, and three companies remained essentially flat.
Best Health Care Stocks to Watch in February 2025
Some of the best health care stocks for February 2025, based on 30-day returns, include Akero Therapeutics Inc., Guardant Health Inc., and Inari Medical Inc. The best-performing health care stocks in ...